Promethean Health

Promethean Health is an Australian biotechnology company focused on the development of cannabinoid-based therapeutics. The company's lead program is the Promethean Health CBD tablet, a plant-derived, highly purified cannabidiol formulation developed as a nanoparticle encapsulation complexation tablet for sublingual delivery. Promethean Health is currently evaluating this candidate in a Phase 3 registration clinical trial for the treatment of adults experiencing mild-to-moderate pain. The company aims to address the significant unmet medical need for well-tolerated and effective pain management options that avoid the adverse effects and abuse potential associated with traditional therapies like opioids.